It has been further demonstrated that PD-1+CD39+CD8+ TEX are tumor specific, are associated with good prognosis in head and neck cancer patients, and predict response to checkpoint blockade in lung cancer patients (21, 22). This evidence concerns the gene CD8A and neoplasm.